10-K/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-K/A

[X] Annual Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

FOR THE YEAR ENDED December 31, 2012 OR

[   ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to

Commission File Number 000-53459

HYBRID COATING TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)

NEVADA	20-3551488
(State of other jurisdiction of incorporation or	(IRS Employer Identification Number)
organization)

950 John Daly Blvd. Suite 260
Daly City, CA 94015
(Address of principal executive offices)

(650) 491-3449
(Registrant’s telephone number, including area code)

Securities registered under Section 12(b) of the Exchange Act: None

Securities registered under Section 12(g) of the Exchange Act:

Common Stock, $ 0.001 par value

Indicate by check mark if the Registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act.
Yes [   ]     No [X]

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes [   ]     No [X]

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]     No [   ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [   ]

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [   ]           Accelerated filer [   ]           Non-accelerated filer [   ]           Smaller reporting company [X]

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [   ]     No [X]

The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $2,933,034 based on the closing price of $0.50 for the common stock on June 29, 2012, the last business day of the registrant’s most recently completed second fiscal quarter.

Number of shares outstanding of the registrant’s class of common stock, as of April 15, 2013 was 6,577,568.

EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to HYBRID Coating Technologies Inc.’s Form 10-K for the period ended December 31, 2012, filed with the Securities and Exchange Commission on April 16, 2013 (the “Form 10-K”), is to furnish interactive data files formatted in XBRL (eXtensible Business Reporting Language) as Exhibit 101 to the Form 10-K in accordance with Rule 405 of Regulation S-T.

No other changes have been made to the Form 10-K. This Amendment No. 1 to the Form 10-K speaks as of the original filing date of the Form 10-K, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way the disclosures made in the original Form 10-K.

ITEM 15. EXHIBITS

Exhibit	Description of Exhibits
Number
3.1	Amended Articles of Incorporation. (1)
3.2	Bylaws, as amended. (1)
3.3	Certificate of Amendment to Articles of Incorporation (2)
4.1	Convertible Debenture Agreement dated April 29, 2011 Pursuant to Regulation D (6)
4.2	Convertible Debenture Agreement dated April 29, 2011 Pursuant to Regulation S (6)
10.1	Stock Purchase Agreement, dated August 18, 2010, by and among Nanotech Industries International Inc. and EPOD Solar Inc. (3)
10.2	Licensing Agreement between Nanotech Industries International Inc and Nanotech Industries Inc. dated July 12, 2010 (4)
10.3	Amendment to the Licensing Agreement previously entered into on the 12th day of July, 2010 (5)
10.4	Securities Purchase Agreement dated April 29, 2011 Pursuant to Regulation D (6)
10.5	Securities Purchase Agreement dated April 29, 2011 Pursuant to Regulation S (6)
10.6	Warrant Agreement dated April 29, 2011 Pursuant to regulation D (6)
10.7	Warrant Agreement dated April 29, 2011 Pursuant to regulation S (6)
10.8	Amendment to articles of incorporation to change the name of the company to “Hybrid Coating Technologies Inc.” (7)
10.9	Approval and adoption of the 2011 Stock Incentive Plan (7)
10.10	Second Amendment to the Licensing Agreement previously entered into on the 12th day of July, 2010 (8)
10.11	Licensing Agreement between Nanotech Industries International Inc and Nanotech Industries Inc. dated October 18, 2011 (9)
10.12	Convertible Debenture Agreement Dated February 21, 2012 (10)
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.

(1) Incorporated by reference to the Registration Statement on Form S-1 (File No. 333-153675), filed with the SEC on September 26, 2008.
(2) Incorporated by reference to the Current Report on Form 8-K filed with the SEC on July 22, 2009.
(3) Incorporated by reference to the Current Report on Form 8-K filed with the SEC on August 30, 2010.
(4) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on August 30, 2010
(5) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on March 14, 2011
(6) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on May 3, 2011
(7) Incorporated as reference to the Schedule 14C filed with the SEC on July 6, 2011
(8) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on July 7, 2011
(9) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on October 18, 2011
(10) Incorporated as reference to the Current Report on Form 8-K filed with the SEC on February 21, 2012

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 17, 2013		HYBRID COATING TECHNOLOGIES INC
		(Registrant)
	By:	/s/ Joseph Kristul
		Name: Joseph Kristul
		Title: President and Chief Executive Officer
		(Principal Executive, Financial and Accounting
		Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ Joseph Kristul		April 17, 2013
Joseph Kristul	President and Chief Executive Officer,
	(Principal executive officer principal financial and accounting officer)
/s/ Alex Trossman		April 17, 2013
Alex Trossman	Director

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph Kristul, Chief Executive Officer of Hybrid Coating Technologies Inc. (the "registrant"), certify that:

1.	I have reviewed this amended annual report on Form 10-K/A of Hybrid Coating Technologies Inc.;
2.	Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3.	Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:
a)	designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)	evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
c)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
a)	all significant deficiencies and material weaknesses in the design or operation of our financial reporting internal controls which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: April 17, 2013

/s/ Joseph Kristul                          
Joseph Kristul
President and Chief Executive Officer,
(Principal executive officer, principal financial and principal accounting officer)

- 1 -

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the amended Annual Report on Form10-K/A of Hybrid Coating Technologies Inc. for the period ending December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Joseph Kristul, Chief Executive Officer, and principal financial officer of Hybrid Coating Technologies Inc., certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1) such amended Annual Report on Form 10-K/A for the year ended December 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in such amended Annual Report on Form 10-K/A for the year ended December 31, 2012 fairly presents, in all material respects, the financial condition and results of operations of Hybrid Coating Technologies Inc.

April 17, 2013

/s/ Joseph Kristul                                   
Joseph Kristul
President and Chief Executive Officer,
(Principal executive officer principal financial and accounting officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

- 1 -

XML

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 1	$ 1,206,936
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 2	1,124,523
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 3	3,385,735
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 4	2,587,856
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 5	4,592,671
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 6	$ 3,712,379

XML

Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 1	34.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 2	34.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 3	34.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 4	34.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 5	$ 0
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 6	$ 0

XML

Schedule of Warrants Valuation Assumptions (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y	Dec. 31, 2011 Y
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 1		126.70%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 2		$ 1.25
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 3		1.48
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 4		3
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 5		1.07%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 6		0
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 1	104.75%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 2	166.04%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 3	0.10
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 4	0.50
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 5	0.50
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 6	1.12
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 7	2
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 8	3
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 9	0.24%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 10	0.43%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 11	$ 0

XML

SENIOR SECURED CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y
Senior Secured Convertible Debentures 1	$ 400,000
Senior Secured Convertible Debentures 2	10.00%
Senior Secured Convertible Debentures 3	$ 0.75
Senior Secured Convertible Debentures 4	533,336
Senior Secured Convertible Debentures 5	1
Senior Secured Convertible Debentures 6	$ 1.25
Senior Secured Convertible Debentures 7	133,360
Senior Secured Convertible Debentures 8	3
Senior Secured Convertible Debentures 9	$ 1.50
Senior Secured Convertible Debentures 10	0
Senior Secured Convertible Debentures 11	21,566
Senior Secured Convertible Debentures 12	21,566
Senior Secured Convertible Debentures 13	120,849
Senior Secured Convertible Debentures 14	20,075
Senior Secured Convertible Debentures 15	46,575
Senior Secured Convertible Debentures 16	26,500
Senior Secured Convertible Debentures 17	200,000
Senior Secured Convertible Debentures 18	14,167
Senior Secured Convertible Debentures 19	25,833
Senior Secured Convertible Debentures 20	240,000
Senior Secured Convertible Debentures 21	79,717
Senior Secured Convertible Debentures 22	200,000
Senior Secured Convertible Debentures 23	$ 178,434

XML

STOCKHOLDERS DEFICIT (Tables)

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Schedule of Warrants Valuation Assumptions [Table Text Block]

Expected volatility	104.75% - 166.04%
Exercise price	$0.10 - $0.50
Stock price	$0.50 - $1.12
Expected life	2 - 3 years
Risk-free interest rate	0.24% - 0.43%
Dividend yield	$nil

Expected volatility	126.7%
Exercise price	$1.25
Stock price	$1.48
Expected life	3 years
Risk-free interest rate	1.07%
Dividend yield	$nil

Schedule of Warrants Activity [Table Text Block]

	Number of	Weighted Average
	Warrants	Exercise Price
Outstanding at December 31, 2010	2,018,928	$0.20
Issued	140,000	$1.72
Exercised	-	$0.00
Outstanding and exercisable, at December 31, 2011	2,158,928	$0.28
Issued February 16, 2012	30,000	$0.10
Issued February 23, 2012	230,000	$0.10
Issued November 29, 2012	50,000	$0.50
Exercised March 23, 2011	(220,000)	$0.10
Outstanding and exercisable, at December 31, 2012	2,248,928	$0.29

XML

Schedule of Intangible Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Intangible Asset Schedule Of Intangible Assets 1	$ 1,118,083
Intangible Asset Schedule Of Intangible Assets 2	1,118,083
Intangible Asset Schedule Of Intangible Assets 3	(491,120)
Intangible Asset Schedule Of Intangible Assets 4	(272,540)
Intangible Asset Schedule Of Intangible Assets 5	626,963
Intangible Asset Schedule Of Intangible Assets 6	$ 845,543

XML

COMMITMENT AND CONTINGENCIES (Narrative) (Details)	12 Months Ended
	Dec. 31, 2012
Commitment And Contingencies 1	52.50%
Commitment And Contingencies 2	10.00%

XML

Schedule of Warrants Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Stockholders Deficit Schedule Of Warrants Activity 1	$ 2,018,928
Stockholders Deficit Schedule Of Warrants Activity 2	0.20
Stockholders Deficit Schedule Of Warrants Activity 3	140,000
Stockholders Deficit Schedule Of Warrants Activity 4	1.72
Stockholders Deficit Schedule Of Warrants Activity 5	0
Stockholders Deficit Schedule Of Warrants Activity 6	0.00
Stockholders Deficit Schedule Of Warrants Activity 7	2,158,928
Stockholders Deficit Schedule Of Warrants Activity 8	0.28
Stockholders Deficit Schedule Of Warrants Activity 9	30,000
Stockholders Deficit Schedule Of Warrants Activity 10	0.10
Stockholders Deficit Schedule Of Warrants Activity 11	230,000
Stockholders Deficit Schedule Of Warrants Activity 12	0.10
Stockholders Deficit Schedule Of Warrants Activity 13	50,000
Stockholders Deficit Schedule Of Warrants Activity 14	0.50
Stockholders Deficit Schedule Of Warrants Activity 15	(220,000)
Stockholders Deficit Schedule Of Warrants Activity 16	0.10
Stockholders Deficit Schedule Of Warrants Activity 17	2,248,928
Stockholders Deficit Schedule Of Warrants Activity 18	$ 0.29

XML

INTANGIBLE ASSET

12 Months Ended

Dec. 31, 2012

INTANGIBLE ASSET [Text Block]

NOTE 3– INTANGIBLE ASSETS

On July 12, 2010, the Company entered into a licensing agreement (the “Licensing Agreement”) with Nanotech Industries, Inc., (“NTI”, a privately-held entity deemed a related party by virtue of common ownership and control), for the rights to manufacture and distribute environmentally safe coatings (“Coating Products”) using NTI’s technology. As per the Licensing Agreement, the Company has a three-year exclusivity for all of North America and has the option to obtain rights for the rest of the world on an exclusive perpetual basis, in exchange for the issuance of stock to equal 62.5% of the Company’s total shares. If this option is exercised, NTI would obtain voting control of the Company.

As part of this Licensing Agreement, the Company agreed to pay NTI a one-time licensing fee of $500,000 and a 5% royalty on gross Coating Product sales within North America. The $500,000 cost basis of capitalized license rights (“North American Rights”) is being amortized over a three-year life. On November 22, 2011, the Company sold the Canadian portion of its North American Rights for $150,000 to a related party; Hybrid Coatings Canada Inc., a company whose CEO is a shareholder of, and consultant to, the Company. The proceeds of the sale were recorded as a reduction of the carrying value of the asset, with no gain or loss.

At December 31, 2012 and 2011, management determined, through independent valuation, that the fair value of the North American Rights exceeded the carrying value and no impairment adjustment was deemed necessary. The amount of amortization of the North American Rights for the years ended December 31, 2012 and 2011 was $73,080 and $162,500, respectively.

On March 17, 2011 the Company and NTI amended the Licensing Agreement to now include the territory of the Customs union of Belorussia, Kazakhstan Republic and Russian Federation (the “Russian Territory”), on an exclusive basis for a period of ten years from the date of the signing of this amendment. In exchange for the right to manufacture and sell Coating Products in the Russian Territory (“Russian Rights”), the Company shall pay to the Licensor an ongoing royalty of 7.5%, and a one-time royalty fee of $150,000 (paid during 2011). These capitalized license rights will be amortized over a ten-year period. The amount of amortization for the years ended December 31, 2012 and 2011 was $4,800 and $11,250, respectively. At December 31, 2011, the fair value, through independent valuation of the Russian Rights was determined to be $44,000. As this was determined to be a permanent impairment in value the carrying value of the Russian Rights was reduced by $94,750 and the associated loss was recorded. At December 31, 2012 management determined, through independent valuation, that the fair value of the Russian Rights exceeded the carrying value and no further impairment adjustment was deemed necessary.

On July 7, 2011, a second amendment was made to the Licensing Agreement granting the Company an option (the “Option”) for a period of six months from the signing of this amendment to manufacture and sell Coating Products in the territory of the European Continent (“European Rights”) on an exclusive basis for a period of five years from the date the option is exercised, after which time the European Rights shall continue perpetually on a non-exclusive basis. Upon exercise of this Option, the Company shall pay to the Licensor a one-time royalty fee of $1,250,000 payable within 24 months of the exercise of the Option. On November 29, 2011, the Company exercised the Option, the financing for which was provided by NTI and is recorded in notes payable – related party. The Company has repaid $449,519 to Nanotech related to the option as of December 31, 2012. The license rights shall be amortized over a five year period.

At December 31, 2011, management determined, through independent valuation, the fair value of the European Rights was $692,000, requiring an impairment charge of $537,167. At December 31, 2012, management determined, through independent valuation, that the fair value of the European Rights exceeded the carrying value and no further impairment adjustment was deemed necessary. The Company recorded $140,700 and $20,833 of amortization expense for the years ended December 31, 2012 and 2011, respectively.

On October 18, 2011, the Company and NTI entered into a second Licensing Agreement (“Second Licensing Agreement”) granting the Company an option (“Sealant Option”) to be exercised within six months of the signing of the Second Licensing Agreement, for the manufacturing and sale of environmentally safe adhesives and sealants (“Sealant Products”), for the following:

1.	The Company shall issue to NTI a one-time licensing fee (“Sealant Shares”), an aggregate number of shares of the Company’s restricted common stock which shall give NTI, immediately upon such issuance of shares, an incremental 15% (fifteen percent) ownership stake in the Company.
2.	The Company shall pay to NTI a royalty of 7.5% (seven and one half percent) of gross revenue from the sale of the Sealant Products for the duration of the agreement.

On December 6, 2011, the Company notified NTI of its intent to exercise the Sealant Option. To date, the Company has not issued the Sealant Shares and the Sealant Option has expired. The Company intends to renegotiate the Sealant Option once the Company has determined it has commercial viability.

A summary of the licenses acquired to date from NTI is as follows:

				Carrying
				Value at
License Rights		Term (date) of	Original	December 31,
Overview	Licensed Region	License	cost	2012
A Coating Products	North America	June 12, 2010 3 years	$500,000	$36,463
B Coating Products	Russian Territory	March 17, 2011 10 years	$150,000	$39,200
C Coating Products	European Continent	July 7, 2011 5 years	$1,250,000	$551,300

Intangible assets activity is as follows for the years ended December 31, 2012 and 2011:

		2012			2011
Net intangible asset, beginning of year	$	845,543		$	422,043
Purchases		-			1,400,000
Sale		-			(150,000	)
Impairment		-			(631,917	)
Less: current amortization		(218,580	)		(194,583	)
Net intangible asset, end of year	$	626,963		$	845,543

The balance of intangible assets is as follows as of December 31, 2012 and 2011:

		2012			2011
Intangible assets	$	1,118,083		$	1,118,083
Less, accumulated amortization		(491,120	)		(272,540	)
Intangible assets, net	$	626,963		$	845,543

XML

Schedule of Debt Issued in 2012 using the following assumptions (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 1	166.04%
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 2	$ 0.50
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 3	0.50
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 4	2
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 5	0.25%
Loan Payable Schedule Of Debt Issued In 2012 Using The Assumptions 6	$ 0

XML

INTANGIBLE ASSET (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 M
Intangible Asset 1	62.50%
Intangible Asset 2	$ 500,000
Intangible Asset 3	5.00%
Intangible Asset 4	500,000
Intangible Asset 5	150,000
Intangible Asset 6	73,080
Intangible Asset 7	162,500
Intangible Asset 8	7.50%
Intangible Asset 9	150,000
Intangible Asset 10	4,800
Intangible Asset 11	11,250
Intangible Asset 12	44,000
Intangible Asset 13	94,750
Intangible Asset 14	1,250,000
Intangible Asset 15	24
Intangible Asset 16	449,519
Intangible Asset 17	692,000
Intangible Asset 18	537,167
Intangible Asset 19	140,700
Intangible Asset 20	$ 20,833
Intangible Asset 21	15.00%
Intangible Asset 22	7.50%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 M
Summary Of Significant Accounting Policies 1	$ 250,000
Summary Of Significant Accounting Policies 2	36
Summary Of Significant Accounting Policies 3	60
Summary Of Significant Accounting Policies 4	120
Summary Of Significant Accounting Policies 5	50.00%

XML

Schedule of Debt Issued in 2011 using the following assumptions (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y
Loans Payable Shareholders Schedule Of Debt Issued In 2011 Using The Assumptions 1	100.28%
Loans Payable Shareholders Schedule Of Debt Issued In 2011 Using The Assumptions 2	112.60%
Loans Payable Shareholders Schedule Of Debt Issued In 2011 Using The Assumptions 3	2
Loans Payable Shareholders Schedule Of Debt Issued In 2011 Using The Assumptions 4	0.56%
Loans Payable Shareholders Schedule Of Debt Issued In 2011 Using The Assumptions 5	$ 0

XML

LOAN PAYABLE (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Loan Payable 1	$ 75,000
Loan Payable 2	10.00%
Loan Payable 3	7,500
Loan Payable 4	55,000
Loan Payable 5	27,500
Loan Payable 6	681,500
Loan Payable 7	15.00%
Loan Payable 8	25.00%
Loan Payable 9	60.00%
Loan Payable 10	47,500
Loan Payable 11	31,100
Loan Payable 12	183,500
Loan Payable 13	19,000
Loan Payable 14	94,500
Loan Payable 15	50,000
Loan Payable 16	20,000
Loan Payable 17	50,000
Loan Payable 18	150,000
Loan Payable 19	50,000
Loan Payable 20	19,005
Loan Payable 21	16,668
Loan Payable 22	2,230
Loan Payable 23	$ 14,438

XML

LOANS PAYABLE SHAREHOLDERS (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 M
Loans Payable Shareholders 1	$ 177,866
Loans Payable Shareholders 2	60,000
Loans Payable Shareholders 3	117,502
Loans Payable Shareholders 4	45,200
Loans Payable Shareholders 5	147,764
Loans Payable Shareholders 6	87,400
Loans Payable Shareholders 7	50,000
Loans Payable Shareholders 8	10,000
Loans Payable Shareholders 9	60,000
Loans Payable Shareholders 10	100,000
Loans Payable Shareholders 11	10,000
Loans Payable Shareholders 12	10,000
Loans Payable Shareholders 13	24
Loans Payable Shareholders 14	1.72
Loans Payable Shareholders 15	85,000
Loans Payable Shareholders 16	25,000
Loans Payable Shareholders 17	50,000
Loans Payable Shareholders 18	3,000
Loans Payable Shareholders 19	50,000
Loans Payable Shareholders 20	24
Loans Payable Shareholders 21	$ 1.48
Loans Payable Shareholders 22	50,000
Loans Payable Shareholders 23	24
Loans Payable Shareholders 24	1.48
Loans Payable Shareholders 25	53,000
Loans Payable Shareholders 26	0
Loans Payable Shareholders 27	50,000
Loans Payable Shareholders 28	3,000
Loans Payable Shareholders 29	30,000
Loans Payable Shareholders 30	24
Loans Payable Shareholders 31	$ 1.48
Loans Payable Shareholders 32	30,000
Loans Payable Shareholders 33	24
Loans Payable Shareholders 34	1.48
Loans Payable Shareholders 35	53,000
Loans Payable Shareholders 36	0
Loans Payable Shareholders 37	50,000
Loans Payable Shareholders 38	5,000
Loans Payable Shareholders 39	25,000
Loans Payable Shareholders 40	24
Loans Payable Shareholders 41	$ 1.48
Loans Payable Shareholders 42	50,000
Loans Payable Shareholders 43	24
Loans Payable Shareholders 44	$ 1.48
Loans Payable Shareholders 45	55,000
Loans Payable Shareholders 46	0
Loans Payable Shareholders 47	60,000
Loans Payable Shareholders 48	6,000
Loans Payable Shareholders 49	60,000
Loans Payable Shareholders 50	60,000
Loans Payable Shareholders 51	66,000
Loans Payable Shareholders 52	66,000
Loans Payable Shareholders 53	100,000
Loans Payable Shareholders 54	20,000
Loans Payable Shareholders 55	25,000
Loans Payable Shareholders 56	24
Loans Payable Shareholders 57	$ 1.48
Loans Payable Shareholders 58	30,000
Loans Payable Shareholders 59	24
Loans Payable Shareholders 60	$ 1.48
Loans Payable Shareholders 61	24,000
Loans Payable Shareholders 62	8,750
Loans Payable Shareholders 63	96,000
Loans Payable Shareholders 64	118,750
Loans Payable Shareholders 65	22,750
Loans Payable Shareholders 66	10.00%
Loans Payable Shareholders 67	22,750
Loans Payable Shareholders 68	26,800
Loans Payable Shareholders 69	8,933
Loans Payable Shareholders 70	17,867
Loans Payable Shareholders 71	100,000
Loans Payable Shareholders 72	1,000
Loans Payable Shareholders 73	5,000
Loans Payable Shareholders 74	70,968
Loans Payable Shareholders 75	110,000
Loans Payable Shareholders 76	50,000
Loans Payable Shareholders 77	24
Loans Payable Shareholders 78	$ 1.48
Loans Payable Shareholders 79	0
Loans Payable Shareholders 80	100,000
Loans Payable Shareholders 81	150,000
Loans Payable Shareholders 82	1,875
Loans Payable Shareholders 83	0
Loans Payable Shareholders 84	150,000
Loans Payable Shareholders 85	100,000
Loans Payable Shareholders 86	150,000
Loans Payable Shareholders 87	50,000
Loans Payable Shareholders 88	300,000
Loans Payable Shareholders 89	16.00%
Loans Payable Shareholders 90	4,000
Loans Payable Shareholders 91	300,000
Loans Payable Shareholders 92	74,000
Loans Payable Shareholders 93	14,800
Loans Payable Shareholders 94	20,000
Loans Payable Shareholders 95	24,000
Loans Payable Shareholders 96	20,000
Loans Payable Shareholders 97	20,483
Loans Payable Shareholders 98	18,317
Loans Payable Shareholders 99	50,000
Loans Payable Shareholders 100	24
Loans Payable Shareholders 101	$ 1.48
Loans Payable Shareholders 102	70,483
Loans Payable Shareholders 103	18,317
Loans Payable Shareholders 104	88,800
Loans Payable Shareholders 105	50,000
Loans Payable Shareholders 106	5,000
Loans Payable Shareholders 107	10,000
Loans Payable Shareholders 108	12,000
Loans Payable Shareholders 109	12,315
Loans Payable Shareholders 110	4,685
Loans Payable Shareholders 111	0
Loans Payable Shareholders 112	12,315
Loans Payable Shareholders 113	625
Loans Payable Shareholders 114	1,875
Loans Payable Shareholders 115	55,000
Loans Payable Shareholders 116	42,685
Loans Payable Shareholders 117	140,000
Loans Payable Shareholders 118	92,075
Loans Payable Shareholders 119	357,430
Loans Payable Shareholders 120	331,490
Loans Payable Shareholders 121	25,940
Loans Payable Shareholders 122	20,000
Loans Payable Shareholders 123	10,000
Loans Payable Shareholders 124	13,000
Loans Payable Shareholders 125	267
Loans Payable Shareholders 126	30,000
Loans Payable Shareholders 127	24
Loans Payable Shareholders 128	$ 1.48
Loans Payable Shareholders 129	40,000
Loans Payable Shareholders 130	15.00%
Loans Payable Shareholders 131	100,000
Loans Payable Shareholders 132	18.00%
Loans Payable Shareholders 133	73,854
Loans Payable Shareholders 134	10,500
Loans Payable Shareholders 135	52,354
Loans Payable Shareholders 136	8,625
Loans Payable Shareholders 137	70,000
Loans Payable Shareholders 138	$ 93,000

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2012

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.

Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech. All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.

Development Stage – The Company complies with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 “Development Stage Entities” in its characterization of the Company as a development stage enterprise.

Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents – The Company maintains various cash balances in one financial institution located in Daly City, California. These balances are fully insured by the Federal Deposit Insurance Corporation, which insures up to $250,000. On occasion, balances may temporarily exceed such coverage. The Company considers all highly liquid debt instruments, which could include commercial paper and certificates of deposits, with an original maturity of three months or less to be cash equivalents. Investments with maturities greater than three months and less than on year are classified as short term investments.

Inventories - Inventories are valued at the lower of cost or market. The cost is determined by using the average cost method.

Intangible Assets - Intangible assets are comprised of intellectual property which is amortized on a straight-line basis over the assets’ respective life, 36 months, 60 months and 120 months. Intellectual property with a perpetual life in not amortized.

Impairment of Long-Lived Assets – Long-lived assets to be held and used are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of such asset may not be recoverable. The determination of recoverability of long-lived assets is based on an estimate of undiscounted future cash flows resulting from the use of the asset or its disposition. Measurement of an impairment loss for long-lived assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or net realizable value.

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.

Income Taxes – Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently payable plus deferred taxes. Deferred income taxes are provided for the estimated income tax effect of temporary differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets are also provided for certain tax loss carryforwards and tax credit carryforwards. A valuation allowance is established to reduce deferred tax assets when it is more likely than not that some portion or all of the deferred tax assets will not be realized. As long as the Company is categorized as a development stage company, the net amount of any potential deferred tax assets will be off-set by such valuation allowance. Deferred income taxes are measured using the enacted tax rates that are assumed will be in effect when the asset and liability basis differences reverse and/or when the tax loss carryforwards and tax credit carryforwards are utilized.

A tax benefit from an uncertain position is recognized if it is "more likely than not" that the position is sustainable, based upon its technical merits. The tax benefit of a qualifying position is the largest amount of tax benefit that is greater than 50 percent likely of being realized upon ultimate settlement with a taxing authority having full knowledge of all relevant information. As of December 31, 2012 and 2011, the Company had not recorded any tax benefits from uncertain tax positions.

Fair Value – ASC 820 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.

Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.

As of December 31, 2012 and 2011, the significant inputs to the Company’s derivative liability calculation were Level 3 inputs.

Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.

Earnings (Loss) per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive.

For the years ended December 31, 2012 and 2011, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:

	Year Ended December 31,
	2012	2011
Convertible debt	1,206,936	1,124,523
Stock warrants	3,385,735	2,587,856
	4,592,671	3,712,379

Recently Issued Accounting Pronouncements – The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

Subsequent Events – The Company has evaluated all transactions occurring between the year ended December 31, 2012, and through the date of issuance of the consolidated financial statements for disclosure consideration.

XML

CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 M
Convertible Debentures 1	$ 1,201,000
Convertible Debentures 2	119,500
Convertible Debentures 3	36
Convertible Debentures 4	10.00%
Convertible Debentures 5	1.4
Convertible Debentures 6	1.40
Convertible Debentures 7	1
Convertible Debentures 8	$ 2.00
Convertible Debentures 9	1.45
Convertible Debentures 10	1.45
Convertible Debentures 11	1
Convertible Debentures 12	$ 2.10
Convertible Debentures 13	558,248
Convertible Debentures 14	46,721
Convertible Debentures 15	77,787
Convertible Debentures 16	480,461
Convertible Debentures 17	360,461
Convertible Debentures 18	166,721
Convertible Debentures 19	46,721
Convertible Debentures 20	558,248
Convertible Debentures 21	182,810
Convertible Debentures 22	97,023
Convertible Debentures 23	325,136
Convertible Debentures 24	130,651
Convertible Debentures 25	81,274
Convertible Debentures 26	120,100
Convertible Debentures 27	240,200
Convertible Debentures 28	995,364
Convertible Debentures 29	$ 739,775

XML

Schedule of License Acquired From NTI (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y
Intangible Asset Schedule Of License Acquired From Nti 1	3
Intangible Asset Schedule Of License Acquired From Nti 2	$ 500,000
Intangible Asset Schedule Of License Acquired From Nti 3	36,463
Intangible Asset Schedule Of License Acquired From Nti 4	10
Intangible Asset Schedule Of License Acquired From Nti 5	150,000
Intangible Asset Schedule Of License Acquired From Nti 6	39,200
Intangible Asset Schedule Of License Acquired From Nti 7	5
Intangible Asset Schedule Of License Acquired From Nti 8	1,250,000
Intangible Asset Schedule Of License Acquired From Nti 9	$ 551,300

XML

Consolidated Balance Sheets (USD $)	Dec. 31, 2012	Dec. 31, 2011
Current assets
Samples and supplies	$ 0	$ 37,836
Total current assets	0	37,836
Intangible asset, net of accumulated amortization	626,963	845,543
TOTAL ASSETS	626,963	883,379
Current liabilities
Bank overdraft	22,104	40,013
Accounts payable and accrued liabilities	435,245	293,214
Accounts payable and accrued liabilities-related parties	554,633	172,695
Stock payable	15,000	0
Senior secured convertible debentures, net of unamortized discounts of $0 and $21,566, respectively	200,000	178,434
Loans payable, net of unamortized discount of $14,638 and $0, respectively	694,362	27,500
Loans payable - shareholders, net of unamortized discounts of $25,194 and $30,632, respectively	1,062,521	697,568
Note payable - related party	800,481	1,126,831
Total current liabilities	3,784,346	2,536,255
Convertible debentures, net of unamortized discount of $325,136 and $461,225, respectively	995,364	739,775
Derivative liability	166,721	480,461
Total liabilities	4,946,431	3,756,491
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value, 75,000,000 shares authorized, 6,503,568 shares and 5,816,733 shares issued and outstanding, respectively	6,504	5,817
Additional paid-in capital	6,651,428	5,849,115
Deficit accumulated during development stage	(10,977,400)	(8,728,044)
Total stockholders' deficit	(4,319,468)	(2,873,112)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 626,963	$ 883,379

XML

Schedule of Reconciliation of Changes in the Fair Value of Financial Assets and Liabilities (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 1	$ 480,461
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 2	0
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 3	(360,461)
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 4	(77,787)
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 5	0
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 6	0
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 7	46,721
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 8	558,248
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 9	0
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 10	0
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 11	166,721
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 12	480,461
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 13	360,461
Convertible Debentures Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 14	$ 77,787

XML

Statement of Stockholders Equity (USD $)	Common stock [Member]	Additional paid-in capital [Member]	Deficit Accumulated During the Development Stage [Member]	Total
Beginning Balance at Jul. 08, 2010
Issuance of Founders shares for services rendered	$ 3,381	$ 334,719		$ 338,100
Issuance of Founders shares for services rendered (Shares)	3,381,003
Fair value of warrants granted on July 8- re-valued on August 30		2,047,471		2,047,471
Fair value of warrants granted on July 14- re-valued on August 30		849,063		849,063
Exchange of shares for 33,810,035 Shares of Nanotech Industries Intl Inc.	1,821	(1,821)
Exchange of shares for 33,810,035 Shares of Nanotech Industries Intl Inc. (Shares)	1,821,000
Issuance of shares for services rendered	100	134,900		135,000
Issuance of shares for services rendered (Shares)	100,000
Beneficial conversion feature on Senior Secured Convertible Debenture		126,607		126,607
Valuation of warrants issued		273,393		273,393
Exercise of warrants for cash on July 30,2010 - 62,500 shares at $0.40 per share		25,000		25,000
Net loss during the development stage			(4,062,486)	(4,062,486)
Ending Balance at Dec. 31, 2010	5,302	3,789,332	(4,062,486)	(267,852)
Ending Balance (Shares) at Dec. 31, 2010	5,302,003
Issuance of shares as payment for consulting fees on February 9, 2011	30	50,970		51,000
Issuance of shares as payment for consulting fees on February 9, 2011 (Shares)	30,000
Remeasurement of warrants July 14,2010 and Series A warrants		1,179,886		1,179,886
Issuance of shares as payment for consulting fees on May 16, 2011	113	175,925		176,038
Issuance of shares as payment for consulting fees on May 16, 2011 (Shares)	112,928
Fair value of 25,000 warrants issued with loans payable shareholders - May 24, 2011		15,450		15,450
Issuance of shares as payment for consulting fees on June 2, 2011	58	89,842		89,900
Issuance of shares as payment for consulting fees on June 2, 2011 (Shares)	58,000
Issuance of shares for services rendered on June 15, 2011	20	30,980		31,000
Issuance of shares for services rendered on June 15, 2011 (Shares)	20,000
Fair value of 25,000 warrants issued with loans payable shareholders - July 15, 2011		27,915		27,915
Issuance of shares for services rendered on September 6, 2011	40	59,560		59,600
Issuance of shares for services rendered on September 6, 2011 (Shares)	40,000
Replacement of outstanding pre-merger shares on September 7,2011	31	(31)
Replacement of outstanding pre-merger shares on September 7,2011 (Shares)	30,500
Issuance of shares for services rendered on September 7, 2011	10	14,390		14,400
Issuance of shares for services rendered on September 7, 2011 (Shares)	10,000
Issuance of shares for services rendered on September 9, 2011	2	2,878		2,880
Issuance of shares for services rendered on September 9, 2011 (Shares)	2,000
To record shares to be issued with loans payable shareholders		36,000		36,000
Issuance of shares for services rendered on October 31, 2011	27	42,291		42,318
Issuance of shares for services rendered on October 31, 2011 (Shares)	27,302
Issuance of shares for services rendered on November 9, 2011	184	285,016		285,200
Issuance of shares for services rendered on November 9, 2011 (Shares)	184,000
Valuation of warrants issued with Loans payable shareholders		48,710		48,710
Net loss during the development stage			(4,665,558)	(4,665,558)
Ending Balance at Dec. 31, 2011	5,817	5,849,115	(8,728,044)	(2,873,112)
Ending Balance (Shares) at Dec. 31, 2011	5,816,733
Issuance of shares for services rendered on January 31, 2012	18	26,982		27,000
Issuance of shares for services rendered on January 31, 2012 (Shares)	18,000
Fair value of 30,000 warrants issued for services rendered - February 16, 2012		29,136		29,136
Fair value of 230,000 warrants issued for services rendered - February 23, 2012		239,269		239,269
Issuance of shares for services rendered - March 5, 2012	51	66,249		66,300
Issuance of shares for services rendered - March 5, 2012 (Shares)	51,000
Issuance of shares with loans payable to shareholders - March 5, 2012	10	12,990		13,000
Issuance of shares with loans payable to shareholders - March 5, 2012 (Shares)	10,000
Issuance of shares for interest and premium on loan - March 5, 2012	90	92,910		93,000
Issuance of shares for interest and premium on loan - March 5, 2012 (Shares)	90,000
Issuance of shares for cashless exercise of 220,000 warrants on loan - March 23, 2012	205	(205)
Issuance of shares for cashless exercise of 220,000 warrants on loan - March 23, 2012 (Shares)	205,135
Issuance of shares for interest on convertible debentures - May 21, 2012	240	119,860		120,100
Issuance of shares for interest on convertible debentures - May 21, 2012 (Shares)	240,200
Issuance of shares for services rendered - May 21, 2012	50	16,450		16,500
Issuance of shares for services rendered - May 21, 2012 (Shares)	50,000
Issuance of shares for services rendered - August 15, 2012	23	12,352		12,375
Issuance of shares for services rendered - August 15, 2012 (Shares)	22,500
Imputed interest on note payable related party		169,452		169,452
Valuation of warrants issued with Loans payable shareholders		16,868		16,868
Net loss during the development stage			(2,249,356)	(2,249,356)
Ending Balance at Dec. 31, 2012	$ 6,504	$ 6,651,428	$ (10,977,400)	$ (4,319,468)
Ending Balance (Shares) at Dec. 31, 2012	6,503,568

XML

RELATED PARTY TRANSACTIONS (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Related Party Transactions 1	$ 262,000
Related Party Transactions 2	375,000
Related Party Transactions 3	46,000
Related Party Transactions 4	359,000
Related Party Transactions 5	485,468
Related Party Transactions 6	168,530
Related Party Transactions 7	326,350
Related Party Transactions 8	800,481
Related Party Transactions 9	1,126,831
Related Party Transactions 10	80.00%
Related Party Transactions 11	20.00%
Related Party Transactions 12	45,000
Related Party Transactions 13	$ 45,000

XML

LOAN PAYABLE (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Debt Issued in 2012 using the following assumptions [Table Text Block]

Expected volatility	166.04%
Exercise price	$0.50
Stock price	$0.50
Expected life	2 years
Risk-free interest rate	0.25%
Dividend yield	$nil

XML

INCOME TAXES (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Income Taxes 1	$ 7,130,000

XML

CONVERTIBLE DEBENTURES (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Reconciliation of Changes in the Fair Value of Financial Assets and Liabilities [Table Text Block]

		Significant Unobservable Inputs (Level 3) Year Ended December 31,
		2012			2011
Beginning balance	$	480,461		$	-
Total gains		(360,461	)		(77,787	)
Settlements		-			-
Additions		46,721			558,248
Transfers		-			-
Ending balance	$	166,721		$	480,461
Change in unrealized gains included in earnings relating to derivatives still held as of December 31, 2012 and 2011		360,461			77,787

XML

NATURE OF BUSINESS AND GOING CONCERN

12 Months Ended

Dec. 31, 2012

NATURE OF BUSINESS AND GOING CONCERN [Text Block]

NOTE 1 – NATURE OF BUSINESS AND GOING CONCERN

Nature of Business Overview
Hybrid Coating Technologies Inc. (the “Company”, “HCT”), was incorporated in the State of Nevada on July 8, 2010.

On July 27, 2011, the Company by majority vote of shareholders amended its articles of incorporation to change its name to Hybrid Coating Technologies Inc. from EPOD Solar Inc. (EPOD). Further, the name change was approved by the Nevada Secretary of State on September 7, 2011, and the Company’s OTC Bulletin Board trading symbol has been changed to HCTI.ob.

On August 30, 2010, the Company acquired from Nanotech Industries International Inc. ("Nanotech"), a corporation formed pursuant to the laws of Nevada on July 8, 2010, all of the issued and outstanding shares of capital stock of Nanotech ("Nanotech Shares") held by the holders of the Nanotech Shares ("Nanotech Shareholders") (the "Acquisition"). The purchase price for the Acquisition consisted of 3,381,003 shares of common stock, $0.001 par value per share (the " EPOD Common Stock") of the Registrant, issued to Nanotech Shareholders. Nanotech is the surviving and continuing entity and the historical financials following the reverse merger transaction will be those of Nanotech. As a result of such acquisition, our operations are now focused on the manufacturing and sale of Green Polyurethane™, including Green Polyurethane™ Monolithic Floor Coating and Green Polyurethane™ Binder, an alternative non-toxic (isocyanate-free) polyurethane.

Going Concern
The Company also remains highly dependent upon funding from non-operational sources. The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net losses of approximately $11,000,000 since inception, and has a working capital deficit of approximately $3,800,000 as of December 31, 2012. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties.

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support The Company’s working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available the Company may be required to curtail or cease its operations.

XML

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2012	Dec. 31, 2011
Senior Secured Convertible Debentures Unamortized Discount Current	$ 0	$ 21,566
Loans payable- net of unamortized discount	14,638	0
Loans payable -shareholders net of unamortized discounts and premiums	25,194	30,632
Convertible Debentures, net of unamortized discount	$ 325,136	$ 461,225
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares, Issued	6,503,568	5,816,733
Common Stock, Shares, Outstanding	6,503,568	5,816,733

XML

COMMITMENT AND CONTINGENCIES

12 Months Ended

Dec. 31, 2012

COMMITMENT AND CONTINGENCIES [Text Block]

NOTE 11-COMMITMENT AND CONTINGENCIES

The Company has an option expiring July 12, 2013 to issue a controlling stake in the Company amounting to 52.5% to a related party for a perpetual exclusive license to manufacture and sell Nanotech Products for all North America, South America and Europe.

If this option is exercised, the Company will have a similar option for the territory of Asia to issue and additional 10% ownership stake in the Company.

The Company is delinquent on its state and federal payroll tax remittances. The State of California has issued a Notice of State Tax Lien against the property and rights owned by the Company covering interest and penalties for non-payment of payroll remittances.

XML

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2012	Apr. 15, 2013	Jun. 29, 2012
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2012
Trading Symbol	epds
Entity Registrant Name	HYBRID Coating Technologies Inc.
Entity Central Index Key	0001445235
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,577,568
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Public Float			$ 2,933,034
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	FY

XML

SUBSEQUENT EVENTS

12 Months Ended

Dec. 31, 2012

SUBSEQUENT EVENTS [Text Block]

NOTE 12– SUBSEQUENT EVENTS

Subsequent to December 31, 2012, the Company issued 74,000 shares for proceeds of $29,600 for services.

On January 21, 2013 the Company entered into a loan agreement for $78,400 maturing on July 20, 2013. The loan bears interest at 2% per month, with any interest unpaid bearing interest at an additional 2.5% /month. The loan is secured by a legal interest in the Company’s assets for approximately $94,000.

In 2013, the Company negotiated terms on a shareholder loan extending the maturity to December 31, 2013 from January 1, 2013 for an additional premium of $30,000.

In March 2013 the company issued warrants to purchase shares with an exercise price of $0.001 and a 5 year term as follows:

- 450,000 warrants to a related party for payment of three years rent up to end of 2013 .

- 420,000 warrants to a shareholder for consulting services .

- 480,000 warrants to the CEO for back pay.

Subsequent to year end the Company received $300,000 in advances from shareholders.

XML

Consolidated Statements of Operations (USD $)	12 Months Ended		30 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
Revenues	$ 66,642	$ 4,870	$ 71,512
Cost of sales	27,700	4,000	31,700
Gross-margin	38,942	870	39,812
Operating expenses
General and administrative	1,608,055	2,104,639	7,502,480
Impairment of intangible asset	0	631,917	631,917
Amortization of intangible asset	218,580	194,583	491,120
Total operating expenses	1,826,635	2,931,139	8,625,517
Loss from operations	(1,787,693)	(2,930,269)	(8,585,705)
Other income (expense)
Loss on extinguishment of debt	(22,750)	(79,717)	(102,467)
Change in fair value of derivative liability	360,461	77,787	438,248
Interest expense	(799,374)	(1,733,359)	(2,727,476)
Net loss	$ (2,249,356)	$ (4,665,558)	$ (10,977,400)
Basic and diluted net loss per common share	$ (0.36)	$ (0.85)
Basic and diluted weighted average number of common shares outstanding	6,316,699	5,501,026

XML

CONVERTIBLE DEBENTURES

12 Months Ended

Dec. 31, 2012

CONVERTIBLE DEBENTURES [Text Block]

NOTE 6 – CONVERTIBLE DEBENTURES

On April 29, 2011, the Company issued convertible debentures for proceeds of $1,201,000 and on February 21, 2012, issued an additional $119,500 (“Debentures”) with a maturity of 36 months and a coupon rate of 10% per annum payable in cash or capital stock at the Company’s discretion. The debentures are held by third parties and by non-controlling shareholders, and are convertible as follows:

April 29, 2014 convertible debentures

-by dividing the conversion amount by a conversion factor of 1.4 yielding Units of the Company where each Unit (at a price of $1.40 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.00 per share and a maturity at April 29, 2014. Warrants are exercisable at the option of the holder at any time prior to maturity.

February 21, 2015 convertible debentures:

-by dividing the conversion amount by a conversion factor of 1.45 yielding Units of the Company where each Unit (at a price of $1.45 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.10 per share and a maturity at February 21, 2015. Warrants are exercisable at the option of the holder at any time prior to maturity.

Both debentures carry an anti-dilution provision. The conversion price applicable to the debentures is subject to reset in the event of a Dilutive Issuance (as defined in the debenture agreement) by the Company. A Dilutive Issuance excludes shares or options issued to employees, officers, directors or consultants pursuant to stock option plans approved by the Board of Directors.

We analyzed derivative financial instruments, (the convertible debenture, share purchase and warrants) in accordance with FASB ASC 815, Fair Value Measurements and Disclosures. The embedded conversion features in the convertible debentures and attached warrants should be accounted for as a derivative liability. The warrants contain full ratchet reset features (subject to adjustment for dilutive share issuances) and should be valued as a derivative liability.

The valuation of the derivative liability attached to the debentures arrived at through the use of multinomial lattice models based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the note that were analyzed and incorporated into the model included the conversion feature with the reset provisions and the call/redemption options. Based on these features, there are six primary events that can occur: payments are made in cash; payments are made with stock; the holder converts upon receiving a change notice; the holder converts the note; the Issuer redeems the note; or the company defaults on the note.

The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. interest rates, stock price, conversion price, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. Probabilities were assigned to each of these scenarios over the remaining term of the note based on management projections. This led to a cash flow projection over the life of the note and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability of $558,248 as of April 29, 2011 and of $46,721 at February 21, 2012 for each issuance. The Company recorded the change in the fair value of the derivative liability as a gain of $77,787 as of December 31, 2011, to reflect the value of the derivative liability as $480,461. The Company recorded another gain of $360,461 to reflect the value of the derivative liability as $166,721 as of December 31, 2012.

The Company recorded a corresponding discount of $46,721 and $558,248 against the carrying value of the convertible debentures during the years ended December 31, 2012 and 2011, respectively. The discounts are amortized using the effective interest method over the three year term of the debt. Amortization of the debt discount was $182,810 and $97,023 for the years ended December 31, 2012 and December 31, 2011, respectively, leaving a remaining discount of $325,136 at December 31, 2012. Interest of $130,651 has been accrued for the year ended December 31, 2012 (2011-$81,274). During 2012, $120,100 in interest has been paid through the issuance of 240,200 shares of common stock on May 21, 2012. The balance of the debentures at December 31, 2012 and December 31, 2011, net of the unamortized discount, was $995,364 and $739,775, respectively.

The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy:

		Significant Unobservable Inputs (Level 3) Year Ended December 31,
		2012			2011
Beginning balance	$	480,461		$	-
Total gains		(360,461	)		(77,787	)
Settlements		-			-
Additions		46,721			558,248
Transfers		-			-
Ending balance	$	166,721		$	480,461
Change in unrealized gains included in earnings relating to derivatives still held as of December 31, 2012 and 2011		360,461			77,787

XML

LOANS PAYABLE SHAREHOLDERS

12 Months Ended

Dec. 31, 2012

LOANS PAYABLE SHAREHOLDERS [Text Block]

NOTE 5 – LOANS PAYABLE –SHAREHOLDERS

A shareholder loaned the Company money to pay for Company expenses. The loans are non-interest bearing and unsecured, with no specific terms of repayment or collateral. During the years ended December 31, 2012 and 2011, the shareholder loaned the Company $177,866 and $60,000, respectively. The Company made repayments in the amounts of $117,502 and $45,200 during the years ended December 31, 2012 and 2011, respectively. The balance of the amounts owed to the shareholder at December 31, 2012 and 2011 was $147,764 and $87,400, respectively.

On January 17, 2011, the Company received a loan of $50,000 with a $10,000 premium due at maturity on April 30, 2011. The premium has been expensed to interest. The balance due at December 31, 2012 and 2011 was $60,000 and the loan is currently in default.

On January 21, 2011, the Company entered into a loan with a shareholder for $100,000 to be repaid by May 21, 2011. The loan has a $10,000 premium payable at maturity and includes 10,000 warrants with a maturity of 24 months at an exercise price of $1.72. During the year ended December 31, 2011, the Company paid $85,000. The balance at December 31, 2012 and 2011 was $25,000 and the loan is currently in default.

On March 2, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $50,000 to be repaid by the maturity date of May 2, 2011. The loan had a $3,000 premium payable at a maturity and included 50,000 warrants with a maturity of 24 months at an exercise price of $1.48 per share. In the event of default, the shareholder will receive an additional 50,000 warrants with a maturity of 24 months and an exercise price of $1.48. During the year ended December 31, 2011, the Company paid $53,000 and the balance at December 31, 2012 and 2011 was $0.

On March 8, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder had agreed to loan the Company $50,000 to be repaid by the maturity date of May 8, 2011. The loan had a $3,000 premium payable at a maturity and included 30,000 warrants with a maturity of 24 months at an exercise price of $1.48 per share. In the event of default, the shareholder will receive an additional 30,000 warrants with a maturity of 24 months and an exercise price of $1.48. During the year ended December 31, 2011, the Company paid $53,000 and the balance at December 31, 2012 and 2011 was $0.

On May 24, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder has agreed to loan the Company $50,000 to be repaid by the maturity date of August 24, 2011. The loan had a $5,000 premium payable at maturity and included 25,000 warrants with a maturity of 24 months at an exercise price of $1.48 per share. In the event of default, the shareholder will receive an additional 50,000 warrants with a maturity of 24 months and an exercise price of $1.48 per share. The shareholder had an option to convert this loan into future convertible debentures. During the year ended December 31, 2011, the Company paid $55,000 and the balance at December 31, 2012 and 2011 was $0.

On June 16, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $60,000 to be repaid by the maturity date of October 16, 2011. The loan had a $6,000 premium payable at maturity that was charged to interest expense. The Company has pledged security in the form of 60,000 shares of the Company. In the event of default, the shareholder has the option to retain the 60,000 shares instead of payment of the $66,000 liability. The lender has granted an extension until June 16, 2013. The balance at December 31, 2012 and 2011 was $66,000.

On July 15, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $100,000 to be repaid by the maturity date of October 15, 2011. The loan had a premium of $20,000 payable at maturity and included 25,000 warrants with a maturity of 24 months at an exercise price of $1.48 per share, which the Company has amortized over the three month term and expensed as interest. In the event of default, the shareholder will receive 30,000 warrants with a maturity of 24 months and an exercise price of $1.48 per share. The Company repaid $24,000 of the loan during the year ended December 31, 2011. On November 4, 2011, the lender has granted the Company an extension of the maturity date until June 29, 2012 for an additional $8,750 in interest payable at maturity. The balance at December 31, 2011 was $96,000. On July 1, 2012, the Company entered into a new loan agreement with the shareholder to extend the maturity in exchange for a new loan balance of $118,750. The new maturity date of the loan is December 31, 2013. The Company reviewed the debt modification for debt extinguishment and determined that the $22,750 additional premium caused the fair value of the new debt to exceed the carrying value of the old debt by more than 10%. Accordingly, the Company recorded the additional $22,750 in premium as a loss on debt extinguishment. There is an additional premium of $26,800 payable at maturity. During 2012, $8,933 of this premium was amortized to interest expense leaving an unamortized premium of $17,867 at December 31, 2012.

On July 29, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $100,000 to be repaid by the maturity date of November 29, 2011 which was extended to July 29, 2012. The loan carries an interest payment of $1,000 per month. The Company accrued $5,000 of interest expense as of December 31, 2011. As collateral, the Company pledged 70,968 shares valued at $110,000 at the date of grant. In the event of default, the shareholder will receive 50,000 warrants with a maturity of 24 months and an exercise price of $1.48 per share. The balance of the loan at December 31, 2012 and 2011 was $0 and $100,000, respectively.

On July 31, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder has agreed to loan the Company $150,000 to be repaid by the maturity date of July 31, 2012. The Company received half the funds on August 31, 2011 and the balance on September 12, 2011. $1,875 interest per month is payable for the term of the loan. The balance of the loan at December 31, 2012 and 2011 was $0 and $150,000, respectively.

On February 14, 2012, the shareholder exchanged the two outstanding loans of $100,000 and $150,000 mentioned above and advanced an additional $50,000 for a new loan total of $300,000. The new loan bears interest at 16% per annum with required interest payments of $4,000 per month. The loan matures on December 31, 2013. The balance of the loan at December 31, 2012 was $300,000.

On August 1, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $74,000 to be repaid by the maturity date of August 1, 2012. The loan has a $14,800 premium half payable on signing date and half payable at maturity. In addition 20,000 shares will be issued at a premium valued on September 30, 2011 of $24,000. The 20,000 shares were issued during the year ended December 31, 2012. The premium will be amortized over the term of the loan. During the year ended December 31, 2011, the Company amortized $20,483 of the premium to interest expense, leaving unamortized premium of $18,317. In the event of default, the shareholder will receive 50,000 warrants with a maturity of 24 months and an exercise price of $1.48 per share. The balance at December 31, 2011, net of the unamortized discount, was $70,483. During the year ended December 31, 2012 the Company amortized the remaining $18,317 in premium to interest expense. The balance at December 31, 2012 was $88,800.

On September 21, 2011, the Company entered into a loan agreement with a shareholder, whereby the shareholder has agreed to loan the Company $50,000 to be repaid by the maturity date of September 21, 2012. The Company will pay a cash premium of $5,000 and will issue 10,000 shares at a premium valued on September 30, 2011 of $12,000. The premium will be amortized over the term of the loan. The amortization of the premium of $12,315 and $4,685 has been charged to interest expense with unamortized premium of $0 and $12,315 at December 31, 2012 and 2011, respectively. Interest of $625 per month will be charged for the term of the loan. At December 31, 2012 and 2011, $1,875 of interest expense has been accrued. The balance of the loan at December 31, 2012 and 2011, net of the unamortized discount, was $55,000 and $42,685, respectively. This loan is currently in default.

Except to the extent paid at inception of the loans the premiums described above were fully amortized using the effective interest method over their respective terms and included in interest expense.

The relative fair value of the 140,000 warrants issued in conjunction with the aggregate debt issued in 2011 amounted to $92,075 using the assumptions discussed in the table below. The discounts arising from these warrants have been fully amortized over the lives of the associated notes.

Fair value assumptions:

Expected volatility	100.28% to 112.6%
Expected life	2 years
Risk-free interest rate	0.56%-0.73%
Dividend yield	$nil

During the year ended December 31, 2012, a company owned by the CEO of HCT advanced the Company $357,430 and was repaid $331,490. The balance owed at December 31, 2012 was $25,940. The advances are non-interest bearing and unsecured, with no specific terms of repayment or collateral.

On February 22, 2012, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $20,000 to be repaid by the maturity date of September 22, 2013. The loan had a premium of 10,000 shares that were valued at the issuance date at $13,000. This premium was fully amortized over the term of the loan. The loan bears interest at $267 per month and is payable monthly. In the event of default, the shareholder will receive 30,000 warrants with a maturity of 24 months and an exercise price of $1.48 per share.

On June 8, 2012, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $40,000 to be repaid by the maturity date of October 18, 2012. The loan bears at interest at 15% per annum and is payable monthly. The loan is unsecured, with no collateral and is currently in default.

On July 2, 2012, the Company entered into a loan agreement with a shareholder, whereby the shareholder agreed to loan the Company $100,000 to be repaid by the maturity date of January 2, 2013. The loan bears at interest at 18% per annum and is payable monthly. The loan is unsecured, with no collateral and is currently in default.

During 2012, the Company accrued $73,854 (2011-$10,500) in interest of which $52,354 (2011-$8,625) was paid. The Company also issued 70,000 shares of common stock to a shareholder as payment of for extending the maturity dates of several loans. The fair value of the stock issued was $93,000 based on the stock price on the date of issuance and was recorded as interest expense.

XML

LOANS PAYABLE SHAREHOLDERS (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Debt Issued in 2011 using the following assumptions [Table Text Block]

Expected volatility	100.28% to 112.6%
Expected life	2 years
Risk-free interest rate	0.56%-0.73%
Dividend yield	$nil

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2012

Basis of Presentation [Policy Text Block]

Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.

Principles of Consolidation [Policy Text Block]

Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech. All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.

Development Stage [Policy Text Block]

Development Stage – The Company complies with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 “Development Stage Entities” in its characterization of the Company as a development stage enterprise.

Use of Estimates [Policy Text Block]

Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents [Policy Text Block]

Cash and Cash Equivalents – The Company maintains various cash balances in one financial institution located in Daly City, California. These balances are fully insured by the Federal Deposit Insurance Corporation, which insures up to $250,000. On occasion, balances may temporarily exceed such coverage. The Company considers all highly liquid debt instruments, which could include commercial paper and certificates of deposits, with an original maturity of three months or less to be cash equivalents. Investments with maturities greater than three months and less than on year are classified as short term investments.

Inventories [Policy Text Block]

Inventories - Inventories are valued at the lower of cost or market. The cost is determined by using the average cost method.

Intangible Assets [Policy Text Block]

Intangible Assets - Intangible assets are comprised of intellectual property which is amortized on a straight-line basis over the assets’ respective life, 36 months, 60 months and 120 months. Intellectual property with a perpetual life in not amortized.

Impairment of Long-Lived Assets [Policy Text Block]

Impairment of Long-Lived Assets – Long-lived assets to be held and used are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of such asset may not be recoverable. The determination of recoverability of long-lived assets is based on an estimate of undiscounted future cash flows resulting from the use of the asset or its disposition. Measurement of an impairment loss for long-lived assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or net realizable value.

Revenue Recognition [Policy Text Block]

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.

Income Taxes [Policy Text Block]

Income Taxes – Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently payable plus deferred taxes. Deferred income taxes are provided for the estimated income tax effect of temporary differences between the financial statement and tax bases of assets and liabilities. Deferred tax assets are also provided for certain tax loss carryforwards and tax credit carryforwards. A valuation allowance is established to reduce deferred tax assets when it is more likely than not that some portion or all of the deferred tax assets will not be realized. As long as the Company is categorized as a development stage company, the net amount of any potential deferred tax assets will be off-set by such valuation allowance. Deferred income taxes are measured using the enacted tax rates that are assumed will be in effect when the asset and liability basis differences reverse and/or when the tax loss carryforwards and tax credit carryforwards are utilized.

A tax benefit from an uncertain position is recognized if it is "more likely than not" that the position is sustainable, based upon its technical merits. The tax benefit of a qualifying position is the largest amount of tax benefit that is greater than 50 percent likely of being realized upon ultimate settlement with a taxing authority having full knowledge of all relevant information. As of December 31, 2012 and 2011, the Company had not recorded any tax benefits from uncertain tax positions.

Fair Value [Policy Text Block]

Fair Value – ASC 820 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.

Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.

As of December 31, 2012 and 2011, the significant inputs to the Company’s derivative liability calculation were Level 3 inputs.

Stock-Based Compensation [Policy Text Block]

Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.

Earnings (Loss) per Share [Policy Text Block]

Earnings (Loss) per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive.

For the years ended December 31, 2012 and 2011, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:

	Year Ended December 31,
	2012	2011
Convertible debt	1,206,936	1,124,523
Stock warrants	3,385,735	2,587,856
	4,592,671	3,712,379

Recently Issued Accounting Pronouncements [Policy Text Block]

Recently Issued Accounting Pronouncements – The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

Subsequent Events [Policy Text Block]

Subsequent Events – The Company has evaluated all transactions occurring between the year ended December 31, 2012, and through the date of issuance of the consolidated financial statements for disclosure consideration.

XML

RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2012

RELATED PARTY TRANSACTIONS [Text Block]

NOTE 9– RELATED PARTY TRANSACTIONS

Fees charged by Shareholder
During the years ended December 31, 2012 and 2011, the Company was charged $262,000 and $375,000 by an outside consultant, who is also a shareholder, for professional fees, expenses and commissions. The amounts are included in accounts payable and accrued liabilities related parties. The Company paid $46,000 and $359,000 to the consultant during the years ended December 31, 2012 and 2011, respectively. The Company has an outstanding balance as of December 31, 2012 and 2011 of $485,468 and $168,530, respectively.

Principal Debt Payments
During the year ended December 31, 2012, the Company made Principal payments of $326,350 on its note payable to NTI related to the 2011 acquisition of the license rights for Coatings in Europe. The note matures on November 29, 2013, does not bear interest, and no payments are required prior to maturity. The balance of the note was $800,481 and $1,126,831 at December 31, 2012 and December 31, 2011, respectively.

Shared Administrative Costs
The Company shares office space and certain personnel with NTI. Costs are allocated among the parties based on usage. During 2012 and 2011, the allocation of such shared costs between the Company and NTI was 80% and 20%, respectively. Rent expense for the years ended December 31, 2012 and 2011 was $45,000 and $45,000, respectively.

XML

SENIOR SECURED CONVERTIBLE DEBENTURES

12 Months Ended

Dec. 31, 2012

SENIOR SECURED CONVERTIBLE DEBENTURES [Text Block]

NOTE 7 – SENIOR SECURED CONVERTIBLE DEBENTURES

On August 16, 2010, the Company entered into a securities purchase agreement with a third party for the subscription of senior secured convertible debentures (“SSCD”) for an amount of $400,000. The debentures have a maturity date of August 16, 2012 with a coupon of 10% and convert into shares of common stock of the Company at a price of $0.75 per share. The notes are secured by all assets of the Company. The subscriber also received 533,336 Series A warrants with a maturity of 1 year and an exercise price of $1.25 per share and 133,360 Series B warrants with a maturity of 3 years and an exercise price of $1.50 per share. The debentures and Series A warrants carry registration rights whereby upon the consummation of the reverse merger with Nanotech, the shares underlying the debentures and Series A warrants will be registered as soon as is practicable. All prices and warrants issued have been adjusted for the post-acquisition of Nanotech by HCT.

The unamortized discount of $0 and $21,566 as of December 31, 2012 and 2011, respectively, was as a result of the relative fair value of the Series A and B warrants attached to the SSCD. Amortization of the debt discount was $21,566 and $120,849 for years ended December 31, 2012 and 2011, respectively. The discount is amortized using the effective interest method over the two year term of the debt. Interest of $20,075 was accrued during the year ended December 31, 2012, for an outstanding balance of $46,575 (2011-$26,500) that has been accrued. During the year ended December 31, 2011, $200,000 of the debt was repaid along with $14,167 of accrued interest and $25,833 as an incentive payment for pre-payment. This $240,000 was repaid through the issuance of a Convertible Debenture due April 29, 2014. A loss on extinguishment of debt of $79,717 has been recorded. The balance due at December 31, 2012 and 2011, net of the unamortized discount, was $200,000 and $178,434, respectively. The Company is in default of payment of the debentures which matured on August 16, 2012. No notices have been issued by the debenture holder.

The obligations of the Company under the SSCD will rank senior to all outstanding and future indebtedness of the Company and shall be secured by a first priority, perfected security interest in all the assets of the Company.

XML

STOCKHOLDERS DEFICIT

12 Months Ended

Dec. 31, 2012

STOCKHOLDERS DEFICIT [Text Block]

NOTE 8– STOCKHOLDERS’ DEFICIT

2011

During the year the Company issued 22,000 shares to employees and 462,230 shares to consultants for services with a fair value of $751,336.

On March 14, 2011, the board of directors authorized the extension of the expiration date of the common stock purchase warrants described in Note 6 to February 28, 2014. This extension of the expiration date will apply to the following: (i) the 533,336 Series A warrants issued to a third party pursuant to the SSCD agreement entered into on August 16, 2010; and (ii) the 687,500 remaining stock purchase warrants issued to a consultant on July 14, 2010. The 533,336 Series A warrants and the 687,500 warrants were re-valued using the Black-Scholes method according to the following assumptions:

Expected volatility	126.7%
Exercise price	$1.25
Stock price	$1.48
Expected life	3 years
Risk-free interest rate	1.07%
Dividend yield	$nil

The new value of the 533,336 Series A (see Note 7) and 687,500 July 14, 2010 warrants (see above) was determined to be $1,180,886 and was recognized as an increase in additional paid –in capital and interest expense.

On August 1, 2011 and September 1, 2011 the Company entered agreements with shareholders whereby loan premiums of 20,000 and 10,000 shares respectively would be issued to shareholders. The fair value of these shares was recorded as a reduction in the carrying value of the loans and an increase in additional paid-in capital of $36,000. The Company issued 20,000 shares during the year ended December 31, 2012. The remaining 10,000 shares have not been issued by the Company.

On September 7, 2011, the Company issued 30,500 shares to pre-merger shareholders that were never issued their shares in error.

On June 15, 2011, the Company’s Board of Directors established the 2011 Stock Incentive Plan expiring on June 15, 2016. The Company’s Board of Directors has determined that it would be in the best interests of the Company to adopt and approve a new long-term stock incentive plan which will facilitate the continued use of long-term equity-based incentives and rewards for the foreseeable future. The Company expects equity-based incentives to comprise an important part of the compensation packages needed to attract qualified executives, key employees, directors and consultants to the Company and in providing long-term incentives and rewards to those individuals responsible for the Company’s success. Accordingly, the Company’s Board of Directors approved the plan.

2012

During 2012, the Company issued 141,500 shares to employees and consultants for services with a fair value of $122,175. The shares were valued using the stock price on the date of grant.

During 2012, the Company issued 240,200 shares to the Convertible Debenture holders as payment for one year’s interest totaling $120,100. The shares were valued using the stock price on the date of grant.

During 2012, the Company issued 100,000 shares to a shareholder as interest compensation for loans. 20,000 of the shares were issued for 2011 premiums previously valued and recorded in additional paid-in capital, 70,000 shares were issued as interest compensation and were valued at $93,000 and were charged to interest expense and the remaining 10,000 shares valued at $13,000 were recorded as debt discount for new loan premiums.

During 2012, the Company issued 260,000 warrants to purchase common stock of the Company to consultants for services and 50,000 warrants in conjunction with the issuance of shareholder loans. The warrants were valued using the Black-Scholes option pricing model using the following assumptions:

Expected volatility	104.75% - 166.04%
Exercise price	$0.10 - $0.50
Stock price	$0.50 - $1.12
Expected life	2 - 3 years
Risk-free interest rate	0.24% - 0.43%
Dividend yield	$nil

The value of the warrants (see above) issued to consultants was determined to be $268,405 and was recognized as an increase in additional paid–in capital and expensed as consulting fees. The fair value of the warrants issued for the shareholder loan was $19,005 and the relative fair value of the warrants was $16,868. The relative fair value was recorded as a debt discount against the carrying value of the loan and an increase in additional paid-in capital.

On February 22, 2012, the Company entered an agreement with a shareholder whereby a loan premium of 10,000 shares would be issued to the shareholder. Although the shares had not been issued the Company has recorded a reduction of the loan and an increase in stock payable of $15,000. The fair value of the stock was determined using the stock price on the date of grant.

On March 23, 2012, a warrant holder exercised 220,000 warrants through a cashless option for 205,135 shares. The Company recorded an increase in par value for the shares and a corresponding reduction in additional paid in capital of $205.

Warrants

A summary of the activity in the Company’s warrants during the years ended December 31, 2012 and 2011 is presented below:

	Number of	Weighted Average
	Warrants	Exercise Price
Outstanding at December 31, 2010	2,018,928	$0.20
Issued	140,000	$1.72
Exercised	-	$0.00
Outstanding and exercisable, at December 31, 2011	2,158,928	$0.28
Issued February 16, 2012	30,000	$0.10
Issued February 23, 2012	230,000	$0.10
Issued November 29, 2012	50,000	$0.50
Exercised March 23, 2011	(220,000)	$0.10
Outstanding and exercisable, at December 31, 2012	2,248,928	$0.29

In addition to the regular warrants detailed in the table above, there are issued and outstanding 533,336 Series A warrants with an exercise price of $1.25 per share and a maturity date of February 14, 2014 and 133,336 Series B warrants with an exercise price of $1.50 per share and a maturity date of August 16, 2013.

The intrinsic value of warrants outstanding at December 31, 2012 was $591,430.

Contingent Warrant Issuance

On July 20, 2012, the Company’s board of directors approved the issuance of 300,000 stock purchase warrants, with an exercise price of $0.001 per share and five-year life, from date of issuance, to the Company’s President, Joseph Kristul, contingent on his successful negotiation of a major sales contract. The major sales contract agreement has not yet been reached by the Company.

XML

INCOME TAXES

12 Months Ended

Dec. 31, 2012

INCOME TAXES [Text Block]

NOTE 10 – INCOME TAXES

Deferred income taxes reflect the net effect of:

(a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income taxes reporting purposes, and

(b) net operating loss carryforwards.

No net provision for refundable U.S. Federal income tax has been made in the accompanying statement of operations because no recoverable taxes were paid previously. Similarly, no deferred tax asset attributable to the net operating loss carryforward has been recognized, as it is not deemed more likely than not to be realized.

The effective tax rate of the Company is reconciled to statutory tax rates as follows for the years ended December 31, 2012 and 2011:

	2012	2011
US federal statutory tax rate	34%	34%
Change in US valuation allowance	( 34%)	( 34%)
Effective tax rate	-	-

Deferred tax assets consist of the following as of December 31:

		2012			2011
Net operating loss carryforward	$	3,672,000		$	2,967,000
Valuation allowance		(3,672,000	)		(2,967,000	)
Deferred tax asset	$	-		$	-

The Company has non-capital losses carried forward of approximately $7,130,000 which expire beginning in 2031. They may be utilized to offset future taxable income. Future tax benefits, which may arise as a result of these losses and resource expenditures, have not been recognized in these financial statements.

XML

STOCKHOLDERS DEFICIT (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Stockholders Deficit 1	22,000
Stockholders Deficit 2	462,230
Stockholders Deficit 3	$ 751,336
Stockholders Deficit 4	533,336
Stockholders Deficit 5	687,500
Stockholders Deficit 6	533,336
Stockholders Deficit 7	687,500
Stockholders Deficit 8	533,336
Stockholders Deficit 9	687,500
Stockholders Deficit 10	1,180,886
Stockholders Deficit 11	20,000
Stockholders Deficit 12	10,000
Stockholders Deficit 13	36,000
Stockholders Deficit 14	20,000
Stockholders Deficit 15	10,000
Stockholders Deficit 16	30,500
Stockholders Deficit 17	141,500
Stockholders Deficit 18	122,175
Stockholders Deficit 19	240,200
Stockholders Deficit 20	120,100
Stockholders Deficit 21	100,000
Stockholders Deficit 22	20,000
Stockholders Deficit 23	70,000
Stockholders Deficit 24	93,000
Stockholders Deficit 25	10,000
Stockholders Deficit 26	13,000
Stockholders Deficit 27	260,000
Stockholders Deficit 28	50,000
Stockholders Deficit 29	268,405
Stockholders Deficit 30	19,005
Stockholders Deficit 31	16,868
Stockholders Deficit 32	10,000
Stockholders Deficit 33	15,000
Stockholders Deficit 34	220,000
Stockholders Deficit 35	205,135
Stockholders Deficit 36	205
Stockholders Deficit 37	533,336
Stockholders Deficit 38	$ 1.25
Stockholders Deficit 39	133,336
Stockholders Deficit 40	$ 1.50
Stockholders Deficit 41	$ 591,430
Stockholders Deficit 42	300,000
Stockholders Deficit 43	$ 0.001

XML

INTANGIBLE ASSET (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of License Acquired From NTI [Table Text Block]

				Carrying
				Value at
License Rights		Term (date) of	Original	December 31,
Overview	Licensed Region	License	cost	2012
A Coating Products	North America	June 12, 2010 3 years	$500,000	$36,463
B Coating Products	Russian Territory	March 17, 2011 10 years	$150,000	$39,200
C Coating Products	European Continent	July 7, 2011 5 years	$1,250,000	$551,300

Schedule of lntangibles Activity [Table Text Block]

		2012			2011
Net intangible asset, beginning of year	$	845,543		$	422,043
Purchases		-			1,400,000
Sale		-			(150,000	)
Impairment		-			(631,917	)
Less: current amortization		(218,580	)		(194,583	)
Net intangible asset, end of year	$	626,963		$	845,543

Schedule of Intangible Assets [Table Text Block]

		2012			2011
Intangible assets	$	1,118,083		$	1,118,083
Less, accumulated amortization		(491,120	)		(272,540	)
Intangible assets, net	$	626,963		$	845,543

XML

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	2012	2011
US federal statutory tax rate	34%	34%
Change in US valuation allowance	( 34%)	( 34%)
Effective tax rate	-	-

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

		2012			2011
Net operating loss carryforward	$	3,672,000		$	2,967,000
Valuation allowance		(3,672,000	)		(2,967,000	)
Deferred tax asset	$	-		$	-

XML

Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	$ 3,672,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	2,967,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	(3,672,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	(2,967,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	$ 0

XML

Schedule of lntangibles Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Intangible Asset Schedule Of Lntangibles Activity 1	$ 845,543
Intangible Asset Schedule Of Lntangibles Activity 2	422,043
Intangible Asset Schedule Of Lntangibles Activity 3	0
Intangible Asset Schedule Of Lntangibles Activity 4	1,400,000
Intangible Asset Schedule Of Lntangibles Activity 5	0
Intangible Asset Schedule Of Lntangibles Activity 6	(150,000)
Intangible Asset Schedule Of Lntangibles Activity 7	0
Intangible Asset Schedule Of Lntangibles Activity 8	(631,917)
Intangible Asset Schedule Of Lntangibles Activity 9	(218,580)
Intangible Asset Schedule Of Lntangibles Activity 10	(194,583)
Intangible Asset Schedule Of Lntangibles Activity 11	626,963
Intangible Asset Schedule Of Lntangibles Activity 12	$ 845,543

XML

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		30 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,249,356)	$ (4,665,558)	$ (10,977,400)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation	390,580	751,337	4,511,551
Impairment of samples and supplies	10,136	0	10,136
Interest paid through issuance of shares	213,100	0	213,100
Amortization of intangible asset	218,580	194,583	491,120
Interest expense from revaluation of SSCD warrants	0	1,180,886	1,180,886
Interest expense on beneficial conversion feature related to SSCD warrants	0	0	126,607
Interest imputed on notes payable - related party	169,452	0	169,452
Loss on extinguishment of debt	22,750	79,717	102,467
Loss on impairment of intangible assets	0	631,917	631,917
Change in fair value of derivative liability	(360,461)	(77,787)	(438,248)
Incentive and interest paid on prepayment of debt	0	25,833	25,833
Amortization of debt discounts	260,505	402,740	714,506
Change in operating assets and liabilities
Samples and supplies	27,700	(37,836)	(10,136)
Accounts payable and accrued liabilities	142,031	234,825	449,412
Accounts payable and accrued liabilities related parties	381,938	172,695	554,633
Bank overdraft	(17,909)	40,013	22,104
Net cash used in operating activities	(790,954)	(1,066,635)	(2,222,060)
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of intangible asset	0	150,000	150,000
Net cash provided in investing activities	0	150,000	150,000
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of convertible debentures	119,500	851,000	970,500
Proceeds from issuance of Senior Secured Convertible Debentures	0	0	400,000
Proceeds from exercise of warrants	0	0	25,000
Proceeds from loans payable - shareholders	765,296	894,000	1,731,896
Repayments from loans payable - shareholders	(448,992)	(315,200)	(764,192)
Proceeds from loans payable	681,500	0	758,375
Repayments of note payable - related party	(326,350)	(516,359)	(1,049,519)
Net cash provided by financing activities	790,954	913,441	2,072,060
INCREASE (DECREASE) IN CASH	0	(3,194)	0
CASH, BEGINNING	0	3,194	0
CASH, ENDING	0	0	0
Supplemental disclosure of cash flow information Cash paid during the period for:
Interest paid	83,440	6,000	89,440
Income taxes	0	0	0
Non-cash financing transactions:
Acquisition of intangible asset through issuance of note payable	0	1,400,000	1,900,000
Discount arising from warrants attached to issuance of SSCD	0	0	273,393
Discount arising from loans payable - shareholders	0	92,075	92,075
Transfer of loans and SSCD to convertible debentures	0	310,000	310,000
Reclassification of accrued interest to SSCD	0	14,167	14,167
Shares issued for premium on shareholder loans	28,000	36,000	64,000
Discount arising from loans payable - shareholders	16,868	0	16,868
Fair value of derivative convertible debentures	46,721	558,248	604,969
Cashless exercise of warrants	$ 205	$ 0	$ 205

XML

LOAN PAYABLE

12 Months Ended

Dec. 31, 2012

LOAN PAYABLE [Text Block]

NOTE 4–LOANS PAYABLE

Loans payable include a loan from a non-related party that was issued for $75,000 on November 16, 2010 and was repayable on May 16, 2011 with a 10% premium. This $7,500 premium has been amortized and on April 29, 2011, the lender converted $55,000 of this debt to convertible debentures. The balance at December 31, 2012 and 2011 was $27,500, and the loan is currently in default. The Company has not received any notices from the loan holders with respect to the defaults.

During the year ended December 31, 2012, the Company entered into various short term loans with different terms totaling $681,500 with interest payable monthly at interest rates ranging from 15% to 25% per annum. Some loans incur a penalty of up to 60% of the monthly interest if the interest is not paid on time. During the year, the Company accrued approximately $47,500 in interest and penalties of which $31,100 was paid. Through the date of issuance of these consolidated financial statements, the Company has defaulted on four of these loans totaling $183,500 ; $19,000 maturing on October 1, 2012, $94,500 on January 13, 2013, $50,000 on March 1, 2013 and $20,000 on April 3, 2013. The Company has not received any notices from the loan holders with respect to the defaults.

During the year ended December 31, 2012, the Company issued 50,000 warrants related to a $150,000 loan payable. The fair value of the 50,000 warrants issued in conjunction with the debt issued in 2012 amounted to $19,005 using the assumptions discussed in the table below. This resulted in a relative fair value of $16,668 which was recorded as a debt discount. The discount is amortized over the life of the associated loan payable. Interest expense of $2,230 was recorded from amortization of the debt discount, resulting in an unamortized discount of $14,438 at December 31, 2012.

Expected volatility	166.04%
Exercise price	$0.50
Stock price	$0.50
Expected life	2 years
Risk-free interest rate	0.25%
Dividend yield	$nil

XML

NATURE OF BUSINESS AND GOING CONCERN (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012
Nature Of Business And Going Concern 1	3,381,003
Nature Of Business And Going Concern 2	$ 0.001
Nature Of Business And Going Concern 3	11,000,000
Nature Of Business And Going Concern 4	$ 3,800,000

XML

SUBSEQUENT EVENTS (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2012 Y
Subsequent Events 1	74,000
Subsequent Events 2	$ 29,600
Subsequent Events 3	78,400
Subsequent Events 4	2.00%
Subsequent Events 5	2.50%
Subsequent Events 6	94,000
Subsequent Events 7	30,000
Subsequent Events 8	0.001
Subsequent Events 9	5
Subsequent Events 10	450,000
Subsequent Events 11	420,000
Subsequent Events 12	480,000
Subsequent Events 13	$ 300,000

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Year Ended December 31,
	2012	2011
Convertible debt	1,206,936	1,124,523
Stock warrants	3,385,735	2,587,856
	4,592,671	3,712,379